Monitor whether the company can raise the $250,000 in funding needed to trigger the CEO's salary increase and whether they can achieve the revenue milestones for equity grants. The leadership transition following the founder's death creates execution risk for this early-stage medical device company.
Price Chart
Executive Summary
RemSleep Holdings Inc. (RMSL) announced the passing of its founder, Chairman, and CEO Thomas Wood on February 26, 2026. The board reconstituted with Anita Michaels as Chair and appointed Jeffrey Marshall as new CEO and director, along with Alexander Johnson as a director. Marshall's employment agreement includes a $60,000 base salary (increasing to $120,000 upon raising $250,000 in funding) and potential equity awards up to 7% of fully diluted capitalization upon achieving revenue milestones.
Key Facts
- Founder and CEO Thomas Wood passed away on February 26, 2026
- Anita Michaels (Wood's sister and COO) became Chair of the Board
- Jeffrey Marshall appointed CEO and director effective March 2, 2026
- Alexander Johnson appointed as new director
- Marshall's base salary is $60,000, increasing to $120,000 upon raising $250,000 in funding
- Marshall eligible for stock options representing up to 7% of fully diluted capitalization upon achieving revenue milestones
- Anita Michaels retains financial oversight authority during transition period
- Michaels has unilateral right to terminate Marshall within 30 days without severance
Financial Impact
Potential future equity compensation of up to 7% of fully diluted shares upon milestone achievement; base salary of $60,000 annually ($120,000 after funding threshold)
Risk Factors
- Leadership instability following founder's death
- CEO's compensation and authority are contingent on funding and board approval
- Company may struggle to raise required $250,000 in funding
- Execution risk for commercializing the DeltaWave Nasal Pillow System
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-023628 |
| Document: ea0280036-8k_remsleep.htm | 0001213900-26-023628 |
| Document: 0001213900-26-023628-index-headers.html | 0001213900-26-023628 |
| Document: 0001213900-26-023628-index.html | 0001213900-26-023628 |
| Document: 0001213900-26-023628.txt | 0001213900-26-023628 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 8w ago | 8-K | $0.002100 $0.001500 | ▲ +28.57% | ▲ +29.08% | $0.001400 (+33.33%) |
Jun 4, 2026 20w ago | 8-K | $0.003800 $0.002600 | ▼ −31.58% | ▼ −30.21% | $0.001400 (−63.16%) |
Mar 4, 2026 33w ago | 8-K | $0.006100 $0.006800 | ▲ +11.48% | ▲ +15.89% | $0.001400 (−77.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers